Creatine Memory Meta-analysis: What the Evidence Says
Creatine Memory Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systemati
Quick Answer
Creatine Memory Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 systematic review, 1 preclinical study.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Creatine Memory Meta-analysis: What the Evidence Says
Quick Answer
Creatine Memory Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Commentary: The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. | systematic review | 1 | 2026-04-10 | 10.3389/fnut.2026.1716285 |
| Assessing Cognitive Deterioration After COVID-19 Infection (The ACDC Study): An Exploratory Multimodal Neuroimaging Study | preclinical study | 4 | 2026-05-30 | 10.3390/jcm15114241 |
What The Sources Report
- Commentary: The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. [Citherlet T (2026); evidence level 1]
- A large study in the UK population, albeit based on subjective reporting, found persistent cognitive impairment equivalent to minus three IQ points on a global measure of cognition in subjects with mild COVID-19 infection. [McLaughlin Jonathan (2026); evidence level 4]
- This increased to minus six and minus nine points, respectively, in subjects with persistent COVID-19 symptoms and in those who had been admitted to ITU owing to infection. [McLaughlin Jonathan (2026); evidence level 4]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For creatine memory meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Citherlet T (2026). Commentary: The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis.. DOI: 10.3389/fnut.2026.1716285. PMCID: PMC13105953. PMID: 42039906. https://pmc.ncbi.nlm.nih.gov/articles/PMC13105953/
- McLaughlin Jonathan (2026). Assessing Cognitive Deterioration After COVID-19 Infection (The ACDC Study): An Exploratory Multimodal Neuroimaging Study. DOI: 10.3390/jcm15114241. PMCID: PMC13257671. PMID: 42279104. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13257671/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed June 24, 2026 by Migaku Evidence Review
Related content
